Founded in 2003, AngioScore is a privately owned company that develops, manufactures and markets balloon catheters for coronary and peripheral interventional markets. Located in Fremont, Calif., it develops angioplasty instruments for treatment of cardiovascular diseases. The company operates through a number of distributors located throughout the world. AngioScore has received the Food and Drugs Administration clearance to market AngioSculpt percutaneous transluminal angioplasty scoring balloon catheter for additional peripheral indications.